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The asthma gene PCDH1 encodes Protocadherin-1, a putative adhesion molecule of
unknown function expressed in the airway epithelium. Here, we characterize the localiza-
tion, differential expression, homotypic adhesion specificity and function of PCDH1 in air-
way epithelial cells in asthma.
Methods
We performed confocal fluorescence microscopy to determine subcellular localization of
PCDH1 in 16HBE cells and primary bronchial epithelial cells (PBECs) grown at air-liquid
interface. Next, to compare PCDH1 expression and localization in asthma and controls we
performed qRT-PCR and fluorescence microscopy in PBECs and immunohistochemistry
on airway wall biopsies. We examined homotypic adhesion specificity of HEK293T clones
overexpressing fluorescently tagged-PCDH1 isoforms. Finally, to evaluate the role for
PCDH1 in epithelial barrier formation and repair, we performed siRNA knockdown-studies
and measured epithelial resistance.
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Results
PCDH1 localized to the cell membrane at cell-cell contact sites, baso-lateral to adherens
junctions, with increasing expression during epithelial differentiation. No differences in
gene expression or localization of PCDH1 isoforms expressing the extracellular domain
were observed in either PBECs or airway wall biopsies between asthma patients and con-
trols. Overexpression of PCDH1 mediated homotypic interaction, whereas downregulation
of PCDH1 reduced epithelial barrier formation, and impaired repair after wounding.
Conclusions
In conclusion, PCDH1 is localized to the cell membrane of bronchial epithelial cells baso-
lateral to the adherens junction. Expression of PCDH1 is not reduced nor delocalized in
asthma even though PCDH1 contributes to homotypic adhesion, epithelial barrier formation
and repair.
Introduction
In 2009, our group identifiedProtocadherin 1 (PCDH1) as a susceptibility gene for bronchial
hyperresponsiveness (BHR) and asthma [1]. Subsequent studies in Dutch [2], German [3], and
Danish populations [4] reported associations of different PCDH1 gene variants with multiple
phenotypes of asthma as well as eczema. Since different PCDH1 gene variants were associated
with specific asthma phenotypes including BHR positive [1], early onset [4], and non-allergic
asthma [3], we proposed that PCDH1 may contribute to disease pathogenesis in subgroups of
asthma patients [5].
Recently, we detected strong expression of PCDH1 in the airway epithelium [1]. We found
two different PCDH1mRNA transcripts encoding, respectively, protein isoform-1 (150 kD)
and isoform-2 (170 kD) [1,6] which share the extracellular and transmembrane domains, but
differ in their intracellular domains. While isoform 1 of PCDH1 has a relatively short intracel-
lular tail lacking conserveddomains (CMs), the longer PCDH1 isoform 2 encodes an addi-
tional intracellular domain with three CMs likely involved in signal transduction. In a
subsequent study, we identified a shorter third isoform which lacks the extracellular domain
yet contains the intracellular tail and hypothesized that this isoform 3 may also act as a signal-
ing molecule. Noteworthy, we showed that expression levels of PCDH1 mRNA and protein
isoforms increased during differentiation of primary bronchial epithelial cells (PBECs) cultured
under air-liquid interface (ALI) conditions [6], indicating that PCDH1might contribute to
bronchial epithelial cell differentiation or establishment of the epithelial barrier, a process that
is impaired in asthma [7]. The reduced barrier function and damaged phenotype of the airway
epithelium is thought to contribute to pathogenesis of asthma [8]. Recently, Kozu et al. found
that siRNA silencing of PCDH1 increased epithelial permeability in 16HBE cells suggesting
that PCDH1 is important for the physical barrier of the airway epithelium [9].
At present, more detailed information confirming the specific subcellular localization of
PCDH1 in the airway epithelium is lacking and its contribution to asthma susceptibility is not
fully understood. As PCDH1may act both as a cell-cell adhesion molecule [9] and a signaling
molecule, it is relevant to characterize the subcellular localization of PCDH1 in airway epithe-
lial cells, its adhesive specificity and evaluate its contribution to epithelial barrier function dur-
ing repair after wounding. Moreover, it is not known whether expression or localization of
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PCDH1 is altered in the airway epithelium of subjects with asthma compared to healthy con-
trols. We hypothesized that PCDH1 is required for effective epithelial barrier formation and
repair, and that expression is reduced in asthma [6]. To test our hypothesis, we characterized
expression levels and localization of PCDH1 in ALI cultured PBECs and in airway wall biopsies
from asthma patients and control subjects. Furthermore, we investigated if cells expressing
PCDH1 showed evidence for homotypic adhesion and assessed the functional consequences of
PCDH1 downregulation for airway epithelial barrier function and epithelial repair.
Material and Methods
Plasmid construction
Human PCDH1 cDNA isoform 1 (pCMV-XL4-iso1) and 2 (pCMV-XL6-iso2) plasmids (Ori-
Gene, Rockville,USA) were used as template for PCR using specific primers carryingHindIII
and NotI restriction sites. PCR was performedwith Phusion™ High Fidelity (F553L, Finnzymes,
Fisher Scientific, Landsmeer, The Netherlands). PCR products were incubated withHindIII
and NotI endonucleases (New England Biolabs, Frankfurt, Germany) and subcloned in opti-
mized pcDNA3.1eGFP (kindly provided by Robert Tsien, UCSD) and used for transient trans-
fection). Orientation and cDNA sequence of the resulting expression plasmids were confirmed
by DNA sequencing.
Overexpression of PCDH1 isoforms 1 and 2
16HBE cells were seeded on 12mm glass coverslips (Thermo ScientificMenzel, Landsmeer,
The Netherlands) coated with 30 μg/ml collagen and 10 μg/ml BSA in EMEM. After 24h cells
were transfectedwith 1 μg of expression plasmids encoding either the PCDH1-GFP fusion pro-
teins or GFP (green fluorescent protein) using Lipofectamine1-2000-reagent (Invitrogen Life
Technologies, Bleiswijk, Netherlands) according to the manufacturer’s instructions. At 80–
100% confluence, cells were fixed in 3.5% formalin for 15 min and washed with 1x PBS at
room temperature. Localization of the PCDH1 fusion proteins was monitored by confocal
microscopy.
Plasmids and cell aggregation assay
Clones of HEK293T cells stably expressing human PCDH1-isoform-1-GFP were generated as
describedpreviously [10]. The control vector expressing EGFP was made by digesting the
pLenti6-EGFP destination vector with EcoRV, which removes the Gateway cassette. The vector
backbone was then religated to itself to obtain an EGFP-expressing construct. The pLenti-
PCDH1-isoform-2-EYFP vector was made by first performing an LR reaction between the
PCDH1-isoform-2 entry vector and the pdEYFP vector, resulting in the pdEYFP-PCDH1-iso-
form-2 plasmid. This was then digested with NotI, blunted with Pfu polymerase and digested
with NheI. The resulting fragment was introduced into the pLenti6-PCDH1-isoform-2 vector,
which had been digested with Csp45I, blunted with Pfu polymerase and digested with NheI.
The PCDH1-isoform-2 insert was removed by performing a BP reaction with pDONR207 to
obtain the pLenti6-EYFP destination vector. The Gateway cassette was largely removed by
digesting the latter plasmid with EcoRI and allowing the plasmid to self-ligate. This resulted in
a pLenti6 vector expressing only EYFP. HEK293T cells were cultured in DMEM containing
10% fetal calf serum. For the production of lentiviral particles, HEK293T cells were transfected
with the appropriate pLenti6 plasmid (Invitrogen) together with pMD.G and pCMVDelta
R8.9 (obtained from Dr. Didier Trono, School of Life Sciences, Lausanne, Switzerland). After
48 h, supernatants were filtered through a 0.45 μm filter (Millipore) and added to the target
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cells. 24 h after transduction, cells were transferred to a new culture vessel and antibiotics were
added 24 h later.
Cell aggregation assays were performed by mixing two different combinations of HEK293T
clones with a ratio of 1:1 to give a final concentration of 3×105 cells/ml, followed by rotation
for 4 hours at 37°C. Mixed clones were seeded in 24-well plates on top of coated 12 mm glass
coverslips for better imaging and incubated for 20h at 37°C. Aggregates were then fixed in
3.5% formaldehyde solution for 20 min and washed with 3x PBS at room temperature. Fluores-
cence detectionwas observedusing a Zeiss LSM 780 two photon/single photon confocal laser
scan microscope.
Confocal images were scored by three individual observers, using a grid with 9 random
points to identify a reference cell. This cell expressed either EGFP or YFP. The observers scored
the fraction of cells in contact with the reference cell expressing either the same fluorescent
marker as the reference cell or the other fluorescent marker compared to the reference cell.
Thus, every independent experiment yielded 9 observations of the fraction of cells in contact to
the reference cell either expression the same fluorescent marker of the other. The observerwas
blinded to the clone’s mixtures throughout the image analysis.
Cell culture and Primary Bronchial Epithelial cells (PBECs)
16HBE 14o- (16HBE) cells, an immortalizednormal bronchial epithelial cell line [11] were
donated by Dr D.C Gruenert (Department of Medicine, University of Vermont, and University
of California, SF, USA). 16HBE cells were cultured in Eagle minimum essential medium
(EMEM) (Biowhittaker, Verviers, Belgium) containing 10% FCS (FCS; Hyclone, Logan, UT)
supplemented with 100 U/ml penicillin and 100 μg/ml streptomycin as describedpreviously
[12]. HEK293T-PCDH1 clones were cultured in Dulbecco'sModified Eagle's medium
(DMEM) supplemented with 10% fetal calf serum (FCS; Biowhittaker, Verviers, Belgium) and
puromycin (0.5μg/ml; A11138-03, Gibco1/Life Technologies, Bleiswijk¸ The Netherlands) in
T25-flasks.
A. Bronchial brushings fromUniversity Medical Center Groningen. Tracheobronchial
tissues were obtained according to standard guidelines from left-over tracheobronchial tissue
of donor lungs, of whom no further information was available and treated with pronase, as
describedpreviously [13]. Primary bronchial epithelial cell (PBECs) were cultured on coated
flasks with 30 μg/ml collagen, 30 μg/ml fibronectin, and 10 μg/ml BSA in serum-freehormon-
ally supplemented bronchial epithelium growth medium BEGM (Clonetics, LONZA, Breda,
The Netherlands) and passaged twice. PBECs were seeded in coated permeable polyester mem-
brane (0.4 μm) (Corning-Costar, Corning,NY). After reaching confluence, cells were exposed
to air and cultured under ALI conditions as describedpreviously [12]. Mucociliary differentia-
tion was confirmed between days 14 and 28 after exposure to ALI by transepithelial electrical
resistance (TEER)measurement and by presence of mucus and cilia. The study protocol was
consistent with the Research Code of the University Medical Center Groningen (http://www.
rug.nl/umcg/onderzoek/researchcode/index) and national ethical and professional guidelines
(“Code of conduct; Dutch federation of biomedical scientific societies”; http://www.federa.org).
B. Bronchial brushings fromUniversity Hospital Southampton. Bronchial brushings
were obtained by fiber-optic bronchoscope [14] according to standard procedures from sub-
jects without or with asthma and grown under ALI conditions [15]. These procedures were eth-
ically approved by the Southampton and SouthWest Hampshire Research Ethics Committees
(REC no. 05/Q1702/165, 13/SC/0182 and 09/H0504/109) including written informed consent
received from all volunteers. Asthma was diagnosed by physicians according to the British
Thoracic Society guidelines. Subjects without asthma were healthy subjects selected from the
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University of Southampton volunteer database. They had no history of asthma and no underly-
ing disease. Details of the study subjects are described in Table 1. Different subsets of patients
were used to study differences in either PCDH1 localization or gene expression as sample size
was limited by the number of PBECs available.
Immunofluorescence staining (IF)
A. PCDH1 in 16HBE human bronchial epithelial cells. 16HBE cells were seeded on 12
mm glass coverslips coated as described above. After 24h, cells were transfected with 50 pmoles
of human PCDH1-siRNA targeting Exon 2 (SASI_Hs01_00051867; Sigma-Aldrich, Zwijn-
drecht, The Netherlands) or universal negative control-siRNA (SIC001-10nmol, Sigma-
Aldrich, Netherlands) with Lipofectamine1 RNAiMAX (13778–075, Invitrogen Life Technol-
ogies, Netherlands). 96 h after transfection, cells were fixed with ice-cold acetone:methanol
(1:1) for 20 min, followed by PBS washes.
Next, cells were blocked in 10% normal goat serum in 1% BSA in PBS for 20 min and incu-
bated for 1 h with either 1% BSA in PBS (Negative control) and a mouse monoclonal antibody
PCDH1-EC1, directed towards the N-terminal EC1 domain of human PCDH1 (H00005097-
M01; Abnova, Taipei, Taiwan) diluted in 1% BSA in PBS; followed by an Alexa Fluor1 594
conjugated secondary antibody (Life Technologies Ltd, Bleiswijk, Netherlands) for 1 h at room
temperature. Negative controls were obtained by replacing the primary antibody with 1% BSA
in PBS. All samples were stained with DAPI (D9542-1MG, Sigma-Aldrich, Zwijndrecht, The
Netherlands) diluted 1:50, and mounted in antifade reagent (Citifluor Ltd., London, United
Kingdom). Fluorescence staining was detected using a confocal microscope Leica SP8.
B. PCDH1 localizationduring differentiation in PBECs cultured under ALI conditions
(IF). PBECs from lung donors were grown under ALI conditions at the University Medical
Center Groningen and sacrificed at five time points: 0 (start of air exposure), 7, 14, 21, and 28
days after air exposure. Transwell inserts were washed in PBS supplemented with 0.01% CaCl2
and fixed in acetone:methanol for 5 min. Inserts were subjected to immunofluorescence stain-
ing and confocal microscopy as described above.
C. Double staining (IF) in differentiated PBECs cultured under ALI conditions. PBECs
grown for 28 days under ALI conditions at the University Hospital Southampton and fixed
and stained as described above. For double staining, cells were incubated for 1 h with either 1%
BSA in PBS (negative control) or with primary antibodies also diluted in 1% BSA in PBS.
Sequential immunostaining was as follows: PCDH1-EC1 (H00005097-M01) and Alexa Fluor1
594 conjugated secondary antibody; and later with antibodies directed to E-cadherin (H-108;
Santa Cruz Biotechnology, INC, Heidelberg, Germany), Occludin (18–7431; Invitrogen
Life Technologies Ltd, Bleiswijk, Netherlands), or β-Tubulin IV (T7941, Sigma-Aldrich,
Table 1. Clinical characteristics of asthma and control PBECs cultured in ALI.
Characteristics PBECs
Asthmatics† Control
Subjects (number) 10 11
Sex (male/female) 3/7 5/6
Age (years) (median, range) 37.5 (24–66) 38 (21–70)
FEV1 (% predicted) (median, range) 88 (33.2–112) 102 (83–134.9)
Smoking (no/current/ex) 9/0/1 8/1/2
Inhaled corticosteroids 10 0
†BHR to methacholine was not performed.
doi:10.1371/journal.pone.0163967.t001
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Zwijndrecht, The Netherlands), followed by an Alexa Fluor1 488 conjugated secondary anti-
body (Life Technologies Ltd,). Finally, all samples were treated as mentioned above and studied
by confocal microscopy.
D. PCDH1 in asthma vs. control PBECs cultured under ALI conditions. PBECs derived
from healthy and asthmatic patients (n = 4 per group) grown under ALI conditions for a mini-
mum of 21 days at the University Hospital Southampton were fixed and stained with monoclo-
nal antibody PCDH1-EC1 (H00005097-M01) in combination with the Zenon1 Alexa Fluor1
647 Mouse IgG1 LabellingKit (Z-25008, Life Technologies Ltd, Bleiswijk, Netherlands) accord-
ing to the manufacturer’s instructions.
Fluorescence images were acquired with a 1.4/oil NA, 63X objective on a Leica SP8, Confo-
cal Microscopy (LeicaMicrosystems B.V, Rijswijk, Netherlands). Imaging of DAPI, Alexa
Fluor 488, Alexa Fluor 594 and Alexa Fluor 647 fluorescencewas performed by excitation
using 405, 488, 552 and 638 nm laser lines, respectively. For comparison within each experi-
ment laser intensity and pinhole remained the same whereas optimal gain and offset settings
were chosen specifically for each condition.
qRT-PCR
Healthy and asthmatics PBECs cultured at ALI condition for a minimum of 21 days were sub-
jected to RNA extraction using TRIzol reagent (Invitrogen, Paisley, UK) followingmanufactur-
er’s instructions. Contaminating gDNA was enzymatically removed (DNA-free kit, Ambion,
Austin, USA). RNA template was converted to cDNA with the NanoScript reverse transcrip-
tion kit (PrimerDesign Ltd, Southampton, UK).
Quantitative RT-PCR experiments were performed using 20 ng of cDNA and 5 μl TaqMan
Gene expression master mix (Applied Biosystems1, Life Technologies, Bleiswijk, The Nether-
lands) as previously described [6]. Gene expression was assessed for: PCDH1 (assay exon 1–2
exon, Hs00170174_m1; assay exon 3–4 exon, Hs00260937_m1; Life Technologies, Bleiswijk,
The Netherlands), and a pre-designed assay for E-cadherin/CDH1 (Hs01023894_m1, Life
Technologies, Bleiswijk, The Netherlands) as a house-keeping gene. qRT-PCRs were measured
in a 384-well format on the ABI7900HT cycler. All experiments were performed in duplicates
and analyzed using SDS 2.1 Software. Ct (cycle threshold) values were averaged and normal-
ized to E-cadherin.
Tissue samples
Airway biopsies from asthma patients and matched controls were obtained by fibre-optic bron-
choscopy for immunohistochemical analyses. Tissues were fixed in ice-cold acetone in the
presence of protease inhibitors iodoacetamide (20 mM) and phenylmethylsulphonylfluoride
(PMSF; 2 mM), stored at -20°C for 24 h and then processed into water-soluble glycol methac-
rylate resin [16]. This study was approved by the Local Research Ethics Committee (06/Q1702/
109) and the University Hospital Southampton NHS Foundation Trust Research and Develop-
ment Committee (RHMCH10395).Written informed consent was obtained. Details of the
study subjects are described in Table 2.
Immunohistochemistry –IHC
Glycolmethacrylate (GMA) tissue sections of approximately 2μm were cut using a Leica Super-
cut RM 2065 Microtome and pre-treated with a solution of 0.1% sodium azide and 0.3% hydro-
gen peroxide for 30 min to inhibit endogenous peroxidase and then blocked with culture
medium for 30 min. Then, sections were incubated overnight with either mouse monoclonal
PCDH1-EC1 (H00005097-M01), diluted 1:10, or with TBS (negative control). Following a
PCDH1 Contributes to Airway Epithelial Integrity
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washing step and a two-hour incubation with biotinylated secondary rabbit anti-mouse Ig anti-
body (dilution 1:1200), a furtherwashing step and a 2-h incubation with avidin biotin-peroxi-
dase complex (1:75) were done. Immunoreactivity was revealed using diaminobenzidene and
counter-stained with Mayer's haematoxylin. Staining intensity was assessed using a computer-
ized assessment with the Fiji distribution of Image J [17]. Images were acquired using a 40X
objective on a Nikon Eclipse E600 Photomicroscope (Nikon UK Limited, Surrey, United King-
dom). For each slide, the cross-sectional area of the airway epithelium was assessed based on
the pre-defined inclusion criteria (see below). Image analysis consisted of interactively seg-
menting the immunostained area for each slide to calculate the percentage of the epithelial area
stained. Each slide contained 2 stained sections and providing the epitheliummet the inclusion
criteria an average percentage was calculated. This was repeated twice on different days and the
mean of the three percentages calculated. The observerwas blinded to the sample classification
throughout the image analysis. Inclusion criteria to select epithelium for Image J analysis were
defined as follows: the epithelium was present from basement membrane up to the apical sur-
face of the columnar cells and not damaged or tangentially cut; the epithelium was attached to
underlying tissue and finally, there was no or minimal background (non-specific) staining.
Measurement of epithelial barrier function
To assess epithelial barrier functionwe measured electrical resistance and capacitance of a con-
fluent monolayer of 16HBE cells using the ECIS system (ElectricalCell substrate Impedance
Sensing) as described [12]. First, expression of PCDH1 was downregulated in 16HBE cells by
transfection of either 30 or 50 pmoles PCDH1-siRNA. Positive control protein E-cadherinwas
downregulated by E-cadherin-siRNA (directed against sequence GCAGAAUUGCUCACAUUUC)
(773797 & 773798, Eurogentec, Maastricht, The Netherlands) and universal negative control-
siRNA was used as a negative control, as described above. After 24 h, transfected cells were
reseeded at 105 cells/well on collagen-coated 8-well arrays model 8W10E (Applied Biophysics,
Troy, NY, USA) and resistance was measured for 150 h.
Table 2. Clinical characteristics of subjects used to study differences in PCDH1 expression using immunohistochemistry on human airway wall
biopsies.
Characteristics Control Subjects Mild Asthmatics Severe Asthmatics†
Subjects (number) 8 10 10
Sex (male/female) 6/2 3/7 4/6
Age (years) * 25 (21–38) 20 (18–24) 56 (35–63)
FEV1% of predicted pre b’dil * 100 (85.3–113) 97.7 (82.8–129.6) 46.2 (26.5–65)
FEV1% of predicted post b’dil* 104.8 (89.1–117) 104.4 (91.7–133) 57.5 (29.2–68.5)
Reversibility (%) * 4.5 (0.0–10.0) 7.2 (2.6–16.1) 28.3(0.0–56.0)
PD20 (mg/ml) to methacholine >16 2.522 (0.12–9.11) N.A
Atopy (Yes/No/unknown) 1/6/1 10/0/0 5/5/0
Inhaled Corticosteroids (mcg/day) 0 0 2000 (800–3600)
Oral Corticosteroids (mg/d) 0 0 12
Asthma Control Questionnaire * 0 0.34 (0.0–0.83) 3.3 (0.8–4.86)
Smoking History (Current/ex/No) 0/1/7 0/0/10 2/2/6
N.A = not available; Pre b’dil, = pre bronchodilator; Post b’dil = post bronchodilator.
*Values are presented as mean (range);
†BHR to methacholine was not performed in the severe asthmatics.
doi:10.1371/journal.pone.0163967.t002
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A wounding experiment was also performed using a delayed transfection approach whereas
16HBE cells were directly seeded on collagen-coated 8-well arrays at 5×104 cells/well and
allowed to attach for 24 h before transfection with respective siRNAs as previously described.
Here, 90 h after seeding the transfected cells, the confluent layer was wounded by electropora-
tion using voltage pulses of 5 V and 40 kHz for 30s and the subsequent morphological wound
healing response was monitored by measuring restoration of electrical resistance for another
17 h, as well as the capacitance. Electrical resistance values for all conditions were normalized
to those of the negative control-siRNA condition at the latest measurement prior to wounding
(which was set to 100%). Different designs were used to obtain specific timing of PCDH1
knockdown: either initially during build up of resistance, or during repair after wounding. The
frequency for studying electrical resistance was set at 400 Hz and for capacitance at 32 kHz,
respectively.
Statistical analysis
Experiments were replicated at least three times. Significance of differences was analyzed by
Two-way ANOVA and Mann-Whitney U test using Graph Pad Prism 6. P-values lower than
0.05 were considered statistically significant. Immunohistochemistry scores were quantified by
ImageJ. Mean score values from image analysis were analyzed using the Kruskal-Wallis test for
unpaired samples to compare percentage staining between the three subject groups, and by the
Mann-Whitney U-test for unpaired samples for comparison between separate groups.
Results
PCDH1 localizes at cell-cell contact sites in a bronchial epithelial cell line
First, we aimed to replicate the original observations from the mouse L cell fibroblast overex-
pression assay [18] using a bronchial epithelial cell line. To this end, fluorescently tagged
PCDH1 isoforms 1 and 2 were transfected into 16HBE cells. Both GFP-tagged PCDH1 iso-
forms (Fig 1A–1B) localized at cell-cell contact sites but not in the GFP-transfected cells (Fig
1C). No difference in localization was observedbetween the two PCDH1 isoforms. Next, we
determined by immunofluorescence the subcellular localization of endogenous PCDH1 pro-
tein in 16HBE cells using monoclonal antibody PCDH1-EC1, which detects the extracellular
domains of both PCDH1 isoforms 1 and 2. PCDH1-specific immunoreactivity was specifically
associated with the cell-cell contact sites (Fig 1D). Knockdown of PCDH1 protein decreased
immunoreactivity specifically at cell-cell contact sites (Fig 1E) while the control-siRNA (nega-
tive control) did not decrease PCDH1 staining. Specificity of the PCDH1-siRNA used was con-
firmed by western blot [10].
PCDH1 localized within the lateral border and basal to Adherens and
Tight Junctions in differentiated primary bronchial epithelial cells
Next, we investigated the subcellular localization of PCDH1 using differentiated PBECs derived
from control subjects and cultured for 28 days under ALI conditions. This was done in relation
to the classical adherens junction protein E-cadherin (AJ) and the tight junction (TJ) protein
Occludin using confocal microscopy. We observedboth, E-cadherin and Occludin protein
located at the apico-lateral border of the membrane (Fig 2A and 2B–Top panel). Orthogonal
cross-sections indicated that, while PCDH1 and E-cadherin localize to the cell membrane and
display close proximity, they do not co-localize. Specifically, we observed that membrane stain-
ing of PCDH1 localized basal to E-cadherinwithin the lateral cell borders cell, with no overlap
at all (Fig 2A–Bottom panel). Noteworthy, PCDH1 protein localized even more basal to the
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Occludin signal (Fig 2B, orthogonal cross-sections). Dual-staining of PCDH1 and β-tubulin
protein (as a marker of cilia) confirmed the presence of ciliated cells, but no co-localization
with PCDH1 was observed (Fig 2C).
PCDH1 expression increases during differentiation of PBECs in ALI
culture
Previously, Koning et al. observed a clear increase of PCDH1 mRNA and protein expression
levels in PBECS on the ALI duringmucociliary differentiation [6]. Here, we investigated
whether the subcellular localization of PCDH1 changed during mucociliarydifferentiation.
Therefore, we cultured PBECs at the ALI and stained for PCDH1 on days 0, 7, 14, 21 and 28, in
four independent experiments (Fig 3). We observedno PCDH1 expression at day 0 of air expo-
sure. PCDH1 staining was detected at day 7 and increased over time with the strongest signal
at day 21 and 28 of ALI culture (Fig 3A–3D). It is noteworthy that orthogonal cross-sections in
Fig 3 demonstrate PCDH1 immunoreactivity at cell-cell contacts with a weak signal in basal
Fig 1. PCDH1 localizes to cell-cell contact sites in 16HBE cells. (A-C) To examine the subcellular localization of the PCDH1 isoforms (arrows),
16HBE cells were transfected with either green fluorescent protein GFP-tagged PCDH1-isoform-1 (A), PCDH1-isoform-2 (B) or control GFP-tagged cells
(C). Representative images are shown from confocal z-stacks showing orthogonal cross-sections at the lines marked, and overlaid with DAPI nuclear
stain. Green = PCDH1 isoform-1 or isoform-2; Blue is DAPI (nucleus). Scale bars, 30 μm. (D-E) Representative immunofluorescence overlaid images
showing 16HBE cells untreated (D) and transfected with PCDH1-siRNA (E), both stained with PCDH1-EC1 antibody followed by detection with
secondary goat anti-mouse Alexa Fluor 633 conjugate antibody (red) and nuclear staining with DAPI (blue). Scale bars, 50 μm.
doi:10.1371/journal.pone.0163967.g001
PCDH1 Contributes to Airway Epithelial Integrity
PLOS ONE | DOI:10.1371/journal.pone.0163967 October 4, 2016 9 / 21
Fig 2. PCDH1 localized within the lateral border and basal to Adherens and Tight Junctions in differentiated primary
bronchial epithelial cells. PBECs were grown for mucociliary differentiation using ALI cultures and dual-stained for with (A) E-
cadherin + PCDH1, (B) Occludin + PCDH1, and (C) β-Tubulin + PCDH1. Representative immunofluorescence images from
confocal z-stacks showing orthogonal image cross-sections at the lines marked overlaid with DAPI nuclear stain. Top panel
images showing: (A) E-cadherin (AJ), (B) Occludin (TJ) and (C) β-Tubulin staining, all at z-stack position with strongest staining
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cells and the strongest signal towards the apico-lateral border of the pseudo-stratifiedepithelial
ALI culture (S1 Video). In summary, we observed that PCDH1 localizes at epithelial cell-cell
contacts and displays marked localization in the apico-lateral border in the pseudo-stratified
ALI cultures with increasing expression during differentiation, and no change in subcellular
distribution.
PCDH1 expression levels and subcellular localization are similar
between asthmatics and control subjects
Gene and protein expression levels were determined as well as the localization of PCDH1 in
ALI cultured PBECs and in airway wall biopsies from asthmatics and control subjects. First,
PCDH1mRNA expression levels from differentiated PBECs were quantified by qRT-PCR. In a
subsequent study, the localization pattern of PCDH1 was compared by fluorescencemicros-
copy in ALI cultured PBECs.We observedno significant differences either in gene expression
(Fig 4A), or in PCDH1 expression patterns (Fig 4B), in differentiated PBECs from asthmatic
patients and control subjects.We subsequently investigated expression of PCDH1 by IHC in
airway wall biopsies from asthmatics (both mild and severe) and control subjects. As shown,
(Fig 4C–Left Panel) in control subjects staining for PCDH1 was generally weak or absent.
However in some asthmatics, positive immunoreactivity was observedpredominantly in the
perinuclear region and localized to the baso-lateral membranes in columnar epithelial cells of
the respiratory epithelium, with apical staining often associated with ciliated cells rather than
goblet cells (Fig 4C–Right Panel). Basal cells were negative. PCDH1 expression levels were var-
iable between individuals, and no overall significant differences were found in PCDH1 expres-
sion between controls, mild and severe asthmatics (Fig 4D).
intensity. Middle panels showing: PCDH1 staining. Lower panel images: overlay of the 3 channels taken at the z-stack position
with the strongest PCDH1 signal. E-cadherin, Occludin and β-Tubulin = green; PCDH1 = red and DAPI staining of the
nucleus = blue. Scale bars, 5 μm.
doi:10.1371/journal.pone.0163967.g002
Fig 3. PCDH1 expression increases during differentiation of PBECs ALI cultures. PBECs cultured under ALI cultures until mucociliary
differentiation and were fixed at different time points, namely day 0, 07, 14 and 28. Immunostaining was with monoclonal antibody PCDH1-EC1.
Representative single channel immunofluorescence images were from confocal z-stacks showing orthogonal X-Z cross-sections at the lines marked,
and overlaid with DAPI nuclear stain. Images for (A) 0, (B) 07, (C) 14 and (D) 28 days are shown. PCDH1 = green and DAPI staining of the
nucleus = red. Scale bar, 50 μm.
doi:10.1371/journal.pone.0163967.g003
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Fig 4. PCDH1 expression levels and subcellular localization patterns are similar between asthmatics and control subjects. A.
mRNA expression levels of PCDH1 exon 1–2 (left panel) and exon 3–4 (right panel) were determined in PBECs grown until mucociliary
differentiation under ALI cultures derived from control and asthmatic subjects. Independent values from 6 subjects per group and
median values are shown. B. Representative immunofluorescence images of control (left panel) and asthmatic (right panel) PBECs
grown until mucociliary differentiation using ALI cultures and staining with PCDH1-EC1 monoclonal antibody. PCDH1 = Magenta and
DAPI staining of the nucleus = light-blue. Scale bars, 50 μm. C. Representative images of airway wall biopsies embedded in GMA from
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PCDH1 mediates homotypic adhesion interaction
PCDH1 has been proposed to play a role in mediating cell sorting [18,19]. Therefore, we inves-
tigated the role of PCDH1 isoforms in establishing cell-cell contacts using cultured HEK293T
cells stably overexpressing either GFP or YFP (negative controls), GFP-tagged PCDH1-iso-
form-1 or GFP or YFP-tagged PCDH1-isoform-2. Interaction or adjacent localization of
PCDH1 isoforms strongly suggested the occurrence of homotypic interactions. As shown in
Fig 5A, control HEK293T-cells transfected with either the control YFP or GFP did not show
any tendency for preferential cell-cell contacts as evident from the expected 50% self and 50%
different cells adhering to the reference cell. In contrast, HEK293T cells transfected with
PCDH1 isoform-1 or isoform-2 showed preferential binding to cells expressing PCDH1 (Fig
5C–5E). These data support the notion that PCDH1mediated cell-cell adhesion through
homotypic interactions.
Downregulation of PCDH1 reduces epithelial barrier function and repair
PCDH1 is not a classical cell-cell adhesion molecule as its adhesion properties were reported to
be weak [18]. Therefore, we investigated whether PCDH1 contributes to acquisition and main-
tenance of the bronchial epithelial barrier. First, we tested whether knockdown of PCDH1 by
siRNA in 16HBE cells would affect the build-up of barrier function during growth of the cells
to confluence, using an E-cadherin-siRNA as a positive control for lack of barrier formation
[20]. To this end, untreated 16HBE cells or cells previously transfectedwith either PCDH1-spe-
cific-siRNA, E-cadherin-siRNA or negative control-siRNA were seeded on ECIS wells and
build-up of electrical resistance was measured in real-time. As expected, we observed a clear
increase of resistance in untreated 16HBE cells, reaching a plateau at 100 h, reflecting efficient
formation of cell-cell contacts [12]. In agreement with previous data, knockdown of E-cadherin
by siRNA fully abrogated build-up of resistance during the course of the experiment ( 125 h).
Interestingly, knockdown of PCDH1 resulted in significantly delayed and reduced build-up of
resistance, reaching a plateau at approximately half of the resistance of the control-siRNA
treated cells (Fig 6A). In a subsequent experiment, we tested whether knockdown of PCDH1 in
confluent 16HBE cells might affect the restoration of epithelial barrier after wounding [12].
Here, cells were first seeded on the ECIS wells and transfected after 24 h with either PCDH1-
siRNA, E-cadherin-siRNA or negative control-siRNA during the growth curve, followed by
wounding after reaching confluence. As shown in Fig 6B, under these experimental conditions,
this delayed knockdown of PCDH1 did not affect the build-up of electrical resistance in the
confluent monolayer of 16HBE cells. Measurements of capacitance showed no effect on cell-
matrix interactions (Fig 6C) nor after wounding (Fig 6D). However, immediately after wound-
ing, negative control-siRNA treated cells showed a rapid restoration of electrical resistance,
reaching its original value within approximately 10 h after wounding. In contrast, knockdown
of PCDH1 resulted in delayed repair and incomplete (50%) recovery of the barrier resistance.
These data indicate that loss of PCDH1 affects epithelial barrier function, both during initial
build-up and after wounding of a confluent layer of bronchial epithelial cells. After wounding,
the E-cadherin knockdown, but not the PCDH1 knockdown conditions, display a residual
capacitance. Taken together, these data show that knockdown of PCDH1 does not affect
control (left panel) and asthmatic (right panel) subjects showing immunohistochemical localization of PCDH1 by use of PCDH1-EC1
antibody. Scale bar, 10 μm. D. Expression of PCDH1 in airway wall biopsies was quantified by Image J computer-aided image
analysis. Dot plot showing PCDH1 protein expression in the respiratory epithelium of healthy volunteers, mild asthmatics and severe
asthmatics demonstrated by percentage area staining of the epithelium. Independent values from all subjects per group and median
values are shown.
doi:10.1371/journal.pone.0163967.g004
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Fig 5. PCDH1 mediates homotypic adhesion interaction. Combination of HEK293T cells stably
expressing human PCDH1-isoforms mixed and allowed to adhere in suspension for 4 hours at 37˚C were
plated for 16 h before imaging. (A) The Y-axis values represent the mean of 9 measurement of the fraction of
cells being in contact with a “reference cell”. This one being either identical to the reference cell (SELF) or the
other cell type mixed in with the reference cell (DIFFERENT). SELF (S) represents the % of all aligning cells
with the reference cell which had the same color (i.e. same transfected isoform or empty vector).
DIFFERENT (D) represents the % cells of all cells aligning with the reference cell which were of different
color. The line represents the mean value of the three independent experiments. (B-E) Representative
clones combinations images are shown. (B) GFP * YFP: both HEK293T clones as negative control. (C)
GFP-tagged-PCDH isoform 1 and YFP-control cells. (D) YFP-tagged-PCDH1 isoform 2 and GFP-control
cells. (E) GFP-tagged-PCDH isoform 2 and YFP-control cells. GFP = green and YFP = yellow. Scale bar,
50 μm. *Data not available for YFP-tagged-PCDH1 isoform 1 and GFP-control cells.
doi:10.1371/journal.pone.0163967.g005
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Fig 6. Downregulation of PCDH1 reduces epithelial barrier function and repair. A. Downregulation of
endogenous expression of PCDH1 in 16HBE bronchial epithelial cells reduced and delayed build-up of
electrical resistance during growth of the cells to confluence. Untreated 16HBE cells or cells previously
transfected with either PCDH1-siRNA, or E-cadherin-siRNA or control-siRNA were seeded in duplicates into
ECIS 8-well arrays for real-time measurement of the electrical resistance over a time course of 150 h, at 400
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PLOS ONE | DOI:10.1371/journal.pone.0163967 October 4, 2016 15 / 21
electrical capacitance in 16HBE cultures, indicating that knockdown of 16HBE does not have a
dominant effect on cell-matrix interactions.
Discussion
PCDH1 gene variants are reported to be associated with BHR [1], asthma [1,3,4] and eczema
[2,4]. Here, we show for the first time that PCDH1 isoform 1 and 2 localize to the cell mem-
brane in bronchial epithelial cells, mediating homotypic interaction. PCDH1 localized basal to
Adherens and Tight Junctions along the lateral border in differentiated primary bronchial epi-
thelial cells, with no PCDH1 expression observednear the TJs or the basal bodies of the cilia.
Moreover, we show that this supra-basal lateral cell membrane staining for PCDH1 is increas-
ing during differentiation of PBECs on ALI. No differences were detected in the expression and
localization patterns of PCDH1 in PBECs grown in ALI or in airway wall biopsies from asthma
patients vs. control subjects. Importantly, loss of PCDH1 reduced epithelial barrier function,
both during establishment of the barrier as well as during epithelial repair after damage, indi-
cating that dysregulation of PCDH1might contribute significantly to loss of epithelial integrity
in specific subgroups of asthma patients.
Our data elucidate a dual role for PCDH1 in regulating repair responses of airway epithelial
cells. We recently reported that two PCDH1 isoforms 1 and 2 interact with SMAD3 to affect
TGF-beta induced responses in airway epithelial cells [10]. We now add evidence for the role
of PCDH1 in epithelial barrier function and homotypic cell-cell adhesion. In addition to
asthma, barrier dysfunction has also been implicated in the pathogenesis of other atopic dis-
eases, such as eczema. Co-morbidity studies in asthma, eczema and rhinitis suggest that part of
the overlap in allergic diseasesmay be due to non-IgE mediatedmechanisms [21], and we pro-
pose that loss of epithelial integrity may be one of these mechanisms involved. This hypothesis
is supported by genetic findings on the Fillagrin encoding gene FLG, where loss-of-function
mutations were strongly associated with eczema, and also with asthma in patients with eczema
[22]. Recently, the gene encoding cadherin-related family member 3 (CDHR3), another puta-
tive cell-cell adhesion molecule, was found to be associated with childhood asthma in a genome
wide association study, strengthening the genetic evidence that loss of epithelial barrier func-
tion may be one of the fundamental mechanisms in asthma development [23]. Recently, it was
shown that CDHR3 is involved in binding of RhinovirusC and mediated entering of rhinovirus
C into the host cells [24], providing a model of epithelial susceptibility for viral infections.
The airway epithelium represents the first line of defense of the respiratory tract. Through
intercellular adhesion complexes and the mucociliary layer, it provides a size and ion-selective
Hz. B. Knockdown of endogenous expression of PCDH1 in confluent 16HBE bronchial epithelial cells
affected the restoration of epithelial barrier after wounding. 16HBE cells were seeded in duplicates into 8-well
ECIS arrays and allowed to attach for 24 h. Then, they were transfected with either PCDH1-siRNA, E-
cadherin-siRNA or control-siRNA. Upon 90 h of siRNA transfection cells were wounded by electroporation
using voltage pulses of 5 V and 40 kHz for 30 sec (time is 0 h). Thereafter, electrical resistance was
monitored for 17 h. C. Knockdown of endogenous expression of PCDH1 in 16HBE bronchial epithelial cells
did not affect build of electrical capacitance during growth of the cells to confluence. 16HBE cells transfected
with either PCDH1-siRNA, E-cadherin-siRNA or control-siRNA were seeded in duplicates into ECIS 8-well
arrays for real-time measurement of the electrical capacitance over a time course of 100 h, at 32 Hz. D.
Knockdown of endogenous expression of PCDH1 in confluent 16HBE bronchial epithelial cells does not
affect electrical capacitance of the epithelial barrier after wounding. 16HBE cells were seeded in duplicates
into 8-well ECIS arrays and allowed to attach for 24 h. Then, they were transfected with either
PCDH1-siRNA, E-cadherin-siRNA or control-siRNA. Upon 90 h of siRNA transfection cells were wounded by
electroporation using voltage pulses of 5 V and 40 kHz for 30 sec (time is 0 h). Thereafter, capacitance was
monitored for 10 h. Data was normalized to peak capacitance after wounding. Mean values from four
independent experiments are shown and error lines (dotted) indicate standard error of the mean. * p <0.001
of PCDH1-siRNA compared to control-siRNA (using two-way ANOVA).
doi:10.1371/journal.pone.0163967.g006
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physical barrier to environmental insults [25,26]. In healthy airway epithelium, TJs and AJs
maintain the physical barrier as well as the apico-basal polarity of this highly organized epithe-
lium. The integrity of the airway epithelium in asthmatics is compromised due to a weakened
barrier function [7,27], increased permeability to allergens, detachment of ciliated cells and
loss of cell-cell junctional molecules such as ZO-1 and E-cadherin [28,29]. As a consequence,
the asthmatic epithelium can respond to environmental insults by producing increased
amounts of pro-inflammatory cytokines, which will contribute to a chronically inflamed
phenotype.
Could dysfunction of PCDH1 compromise the airway epithelial barrier of the asthmatic
epithelium?We provide some evidence that this might indeed be the case, although we did so
far not identify the exact subgroup of asthma patients in which this can be conclusively
shown. A role of PCDH1 in epithelial barrier function [9] is strongly suggested by the expres-
sion of PCDH1 at the cell-cell contact sites of airway epithelial cells localizing baso-laterally to
the AJ, and its increased expression during mucociliary differentiation of healthy bronchial
epithelial cells [6], for which adhesion function is an important factor. As, we found that a
decreased of PCDH1 expression results in epithelial barrier dysfunction and an impaired
repair response. The divergent effects of knockdown of PCDH1 on electrical resistance versus
capacitance, with no effect of PCDH1 knockdown on electrical capacitance during 16HBE
growth and during wound repair seem to indicate that the effects of PCDH1 are selective for
epithelial barrier formation due to junctional complex formation at cell-cell contacts, while
cell-matrix adhesion is not affected by PCDH1 loss. Therefore, loss of PCDH1 functionality
may indeed explain some of the phenotypes seen in the airway epithelium of asthmatics. Nev-
ertheless, it remains unknown how PCDH1 would interact with E-cadherin or other mole-
cules of the epithelial adhesion complex to mediate its effect on epithelial barrier function,
how reduced barrier function due to loss of PCDH1 would affect permissiveness of the epithe-
lium to large molecules such as FITC-Dextran, and in what specific subgroup of asthma
patients PCDH1 would show this effect. Further functional studies, that include analysis of
PCDH1 in subcellular fractions as well as identification of protein interaction partners, are
needed to address these questions.
We tested whether PCDH1 was differentially expressed between asthma and control sub-
jects by three approaches, using two sources of primarymaterial. We did not detect differ-
ences in gene expression, protein levels or localization patterns of PCDH1 in PBECs grown at
ALI conditions using an antibody that detects the extracellular portion of PCDH1 isoform 1
and 2, but not isoform 3. However, this study might have been underpowered (n = 4) to detect
differences at the group level, especially since we did not stratify for PCDH1 genotype in our
analyses. The immunohistochemically staining of airway tissues was better powered, but here
we mainly observed large-within-group variability, without significant differences in PCDH1
protein levels or cellular distribution patterns between groups. Using immunohistochemistry,
Kuzo et al. 2015, observedno differences in the distribution of PCDH1 in the nasal tissues of
Japanese patients with chronic rhinosinusitis compared to the airway of asthmatic patients
with similar histological appearance [9]. Since we analyzed PCDH1 localization and expres-
sion using an antibody directed against the extracellular domain, we were unable to differenti-
ate between PCDH1 isoforms that only differ in the intracellular protein domains. Therefore,
we cannot draw any conclusions regarding the regulation of PCDH1 isoforms during epithe-
lial differentiation on ALI and between asthma and control subjects.Moreover, in this
analysis, a role for the PCDH1 genotype, including a potential effect of smoking on gene
expression, was not investigated [30]. Finally, Kuzo et al. suggested that PCDH1 is upregu-
lated by corticosteroids, which may in part explain the increased expression we observed in
asthmatics [9]. Further studies comparing PCDH1 levels in airway tissue between asthmatic
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individuals using ICS and those that are not using ICS might shed light on this important
issue. We conclude that while decreased PCDH1 might contribute to airway epithelial dys-
function in asthma, altered PCDH1 expression levels do not seem to be a shared mechanism
in all asthma patients, and further research will need to address whether loss of PCDH1 con-
tributes to airway epithelial barrier dysfunction in those asthma patients carrying the asthma-
susceptible PCDH1 allele.
In order to further interpret our findings, several strengths and limitations need to be con-
sidered. First, to our knowledge we are the first to identify the localization of PCDH1 isoforms
in bronchial epithelial cell lines using an overexpression system as well as detection of endoge-
nous expression in primary airway epithelium.Moreover, we confirmed the specificity of
PCDH1 staining by PCDH1 knockdown and the different approaches used yielded highly con-
sistent results. A drawback from our study is that we could not perform these studies in asth-
matic subjects and controls stratified for the PCDH1 asthma susceptibility genotypes, since
there was no informed consent to genotype these subjects. The question how PCDH1 gene var-
iants regulate PCDH1 expression or function is therefore still open. Moreover, it is well known
that airway epithelial cells of asthma patients display an immature phenotype characterized by
increased expression of basal cell markers [31]. If a reduced capacity of airway epithelial cells to
differentiate is a basic defect that partly determines asthma susceptibility, the use of well differ-
entiated airway epithelial cells may have introduced a bias to our studies. The same holds true
for the analysis of airway wall biopsies. Finally, differences in the localization of specific
PCDH1 isoforms or changes in the balance between isoforms 1 and 2 could not be determined
as the antibodies specific for PCDH1 isoforms, generated by us in the context of previous stud-
ies [6], did not meet the validation criteria for specificity and reproducibility of immunostain-
ings. We suggest that further work should be performed to identify the relative expression and
specific roles of PCDH1 isoforms.
In conclusion, we provide strong evidence that PCDH1 may function as a cell-cell adhesion
molecule involved in epithelial repair. We showed that PCDH1 localizes to cell-cell contact
sites apicolaterally in differentiated airway epithelium and that PCDH1 expression becomes
stronger toward the most differentiated cells. Importantly, we provide evidence that PCDH1
function is relevant for maintaining epithelial barrier and that loss of functional PCDH1 repre-
sents a potential mechanism for development of asthma and BHR. This may lead to novel ther-
apeutic approaches aiming to improve or reconstitute epithelial barrier function in asthma.
Supporting Information
S1 Fig. PCDH1 localizedwithin the lateral border and basal to Adherens and Tight Junc-
tions in differentiated primary bronchial epithelial cells. E-cadherin,Occludin and β-
Tubulin = yellow; PCDH1 = magenta and DAPI staining of the nucleus = light-blue. Scale
bars, 5 μm.
(TIF)
S1 Video. PCDH1 localization at cell-cell contacts with strongest signal towards the apico-
lateral borders of the pseudo-stratifiedepithelial ALI culture. Representative PBECs cul-
tured at ALI culture until mucociliarydifferentiation were fixed at day 28, stained with
monoclonal antibody PCDH1-EC1 and labeled with Alexa Fluor1 488 conjugated secondary
antibody. Overlay confocal images of PCDH1 (green) and DAPI staining of the nucleus (red)
were taken using a laser-scanning confocal microscope. Frames were taken every 0.5 μm, from
basal to apical. Scale bar, 50 μm.
(7Z)
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